Best ED Telehealth Providers in 2026 — Ranked & Reviewed
What most online erectile dysfunction platforms actually sell is a compounded multi-ingredient product: sildenafil, tadalafil, or both together in a dissolvable troche or a chewable tablet. None of those is an FDA-approved single-agent therapy. Phase 3 trials and FDA review sit behind branded Cialis (tadalafil), Viagra (sildenafil), Levitra (vardenafil) and Stendra (avanafil), plus their FDA-approved generics, and behind nothing else. That does not make either path wrong. It makes the difference one of evidence and price. Every ED telehealth provider on the register is ranked below on price transparency, on drug formulary, on state availability, on pharmacy-partner disclosure, and on honest framing of FDA status. We also note where the care overlaps with GLP-1 weight-loss treatment, since losing weight improves erectile function in many men.
Lowest verified price: $171/mo1 provider compared
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
1 ed telehealth providers compared · independently scored against our six-factor methodology.
Rankings updated August 2026
Quick Picks: Top 1
| # | Provider | Score | |
|---|---|---|---|
| 1 | MyDrHank | Visit |
A seller that will not show a price before an intake loses points on Value and carries that note in its review. Withholding the number is itself a finding. How we score →
Detailed Reviews
MyDrHank
Best for: an oral route if you will not self-inject
This entry covers the erectile-dysfunction side of MyDrHank, whose legal name is Dr. Hank, LLC. Four products sit on the list: sildenafil in generic form, tadalafil both generic and daily, and MDH Drive, which dissolves rapidly and pairs sildenafil with tadalafil. Every case gets reviewed online by providers holding U.S. licenses, and three partner pharmacies are named. Plans are itemized at one, three and six months, the cheapest being $25/mo for generic sildenafil, with free shipping and nothing to commit to.
Score Breakdown
Pros
- ✓Semaglutide at $171 a month, within the normal band around this register's $199 median for the same drug and form
- ✓Publishes a price on its own site before the medical questionnaire, so it can be compared without handing over health information
- ✓No FDA warning letter matched this operator when we searched our enforcement register
- ✓Both oral and injectable options are on record, so the format is a choice rather than a condition
Cons
- ✗No state list is on record here, so whether it serves your state cannot be confirmed from this page
- ✗No dispensing pharmacy is named in our record, so its accreditation cannot be looked up from here
- ✗Its semaglutide and tirzepatide are compounded rather than FDA-approved, so they have not been reviewed by the agency for safety, effectiveness or manufacturing quality
Reading an online ED offer
Compounded multi-ingredient troches and chewables, built on sildenafil or tadalafil, are what most online ED platforms actually sell. FDA-approved single-agent tablets are a different product. Buying either one is defensible. Not knowing which one is in the box is not.
What to check
- Single agent, or a compounded combination. Phase 3 trials studied generic sildenafil and tadalafil at defined doses, and both hold FDA approval. Compounded troches and chewables carry the same molecules in combinations no trial has tested. That is a different evidence position rather than a disqualifying one.
- The fulfillment pharmacy, named. Where the product is compounded, the pharmacy filling it can be named, and once named it can be traced through its state Board of Pharmacy. A reference to a 'partner pharmacy network', with no name attached, leaves nothing to trace.
- Cardiac questions in the intake. ED that appears suddenly and for no obvious reason can be an early cardiovascular marker. PDE5 inhibitors are also contraindicated alongside nitrates. An intake asking about cardiac history and current medications is practicing medicine. One asking only for a shipping address is taking an order.
Red flags
- Neither pharmacy nor licensing disclosed. The 503A or 503B pharmacy behind a compounded ED product is something a seller can state plainly, and many do. Where a site offers 'our pharmacy network' and stops there, the contents of the box stay unverified.
- A compounded product described as approved. No compounded sildenafil or tadalafil combination holds FDA approval, and none has run the pivotal trials at the doses being sold. Marketing that positions such a product as the equivalent of Viagra or Cialis, without stating the difference, misleads by construction.
- Nitrates and cardiac history never asked about. Combining a PDE5 inhibitor with a nitrate is dangerous, and prescribing straight past new-onset ED can bury the cardiac workup it may call for. An intake carrying neither question has dropped a safety step and called the result convenience.
- The tier you join is not the tier you stay on. Entry tiers here are priced low, and the step up to a standard or high-frequency tier is often steep enough to double the monthly figure. What a platform charges on an ongoing basis is the number that counts.
Every seller listed above is scored on these criteria under our six-dimension methodology, with prices re-checked against the seller’s own live site.
How we rank, and what counts as “legit”
Scoring for every provider on this page runs against our published six-factor rubric[1]: value, effectiveness, user experience, trust & safety, accessibility and support.
Each of Wegovy, Zepbound, Ozempic and Mounjaro holds its own separate FDA approval under its own NDA number[4][5]. Published Phase 3 efficacy for semaglutide at 2.4 mg (~14.9% mean weight loss across 68 weeks) comes from STEP 1[6]; those for tirzepatide (~20.9% at the 15 mg dose over 72 weeks) come from SURMOUNT-1[7]. In 2025 the SURMOUNT-5 head-to-head set the two against each other[8].
How much of an anti-obesity medication is covered varies widely between state Medicaid programs and between commercial plans[9][10]. Under IRS Publication 502, compounded GLP-1s and brand-name ones alike are generally FSA/HSA eligible where a prescription exists[11].
Frequently Asked Questions
Sources & methodology — as of August 2026
- 1.GLP Watchdog — GLP-1 Pricing Index 2026 (our independent dataset)— GLP Watchdog.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 5.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
- 8.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Garvey WT et al.)— New England Journal of Medicine.PMID: 40334173.
- 9.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 10.CMS — Medicaid prescription drug coverage policy (state-by-state)— Centers for Medicare & Medicaid Services.
- 11.IRS Publication 502 — Medical and Dental Expenses (HSA/FSA eligibility)— Internal Revenue Service.